Vascular Inflammation Manufacturers, Suppliers & Companies
-
Manufacturerbased in Huntsville, ALABAMA (USA)
SynVivo is a cell-based microfluidic organ-on-chip platform that provides a biologically realistic microenvironment for the real-time study of cellular behavior, drug delivery, and drug discovery. This proprietary technology links the high-tech ...
Screening, Assay and New Model Development Services
The SynVivo platform has been validated for accurate prediction of in vivo responses. Use this unique in vitro platform for realistic assessment of drug delivery, analysis of cell-cell, cell-drug, and their underlying mechanisms. Recreate cellular ...
CONTACT SUPPLIER -
Manufacturerbased in Galveston, TEXAS (USA)
ChrysalisBioTherapeutics, Inc. is a clinical stage biopharmaceutical company developing regenerative drugs that mimic the body´s natural signals to activate endothelial cells and stem cells to stimulate tissue repair and restore normal tissue ...
Chrysbio - Model TP508 (Chrysalin) - Peptide Technology
TP508 is as an injectable drug used to mitigate vascular damage, hemorrhage, and inflammation observed in ARDS induced by viral infection (COVID19) or nuclear radiation. TP508 also activates stem cells to regenerate ...
CONTACT SUPPLIER -
Manufacturerbased in Tampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...
-
Technologybased in South San Francisco, CALIFORNIA (USA)
Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders. Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and ...
Neurona - Model NRTX-1001 - Inhibitory Neuron Cell Therapy
Neurona’s lead product candidate, NRTX-1001, comprises human MGE-type inhibitory GABAergic interneurons derived from pluripotent stem cells. NRTX-1001’s first indication is for the treatment of drug-resistant focal epilepsy, which is a ...
CONTACT SUPPLIER -
Manufacturerbased in Berlin, GERMANY
As a technology and service provider to the biopharmaceutical industry nanoPET focuses on the R&D, production as well as marketing of innovative drug substances for diagnostic imaging. Nanotechnology is a key element of our business and allows us to ...
NiraWave - Optical Contrast Agents
NiraWave™ optical contrast agents are novel dyes and nanomaterials ideal for the study of vascular fine structure and disease-related vascular changes. ...
CONTACT SUPPLIER -
Manufacturerbased in Billerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
-
Technologybased in South San Francisco, CALIFORNIA (USA)
At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...
-
Technologybased in Miami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
-
Manufacturerbased in Melbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you